Keynote speakers

Roy Adams
PhD, Assistant Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, USA

Katerina Akassoglou
PhD, Professor, Department of Neurology, University of California, San Francisco, Senior Investigator, Gladstone Institute of Neurological Disease Director, Center for Neurovascular Brain Immunology, Gladstone Institutes, UCSF, USA

Rebecca Barnstaple
PhD, International Institute for Critical Studies in Improvisation, University of Guelph, Canada

Haroon Burhanullah
MD, Assistant Professor, Division of Geriatric and Neuropsychiatry, Director Consult Liaison service-ED/PES, Johns Hopkins Medicine , USA

Maria Chountoulesi
MSc, PhD, Pharmacist, UNI-PHARMA S.A., Greece

Christina Dalla
PhD, Professor, Pharmacology, 2nd Dep. of Obstetrics-Gynecology, Aretaieio Hospital, Medical School, National & Kapodistrian University of Athens, Greece

Samuel Danso
PhD, Senior Lecturer, School of Computer Science, University of Sunderland, UK & Fellow, Centre for Dementia Prevention & Centre for Clinical Brain Sciences, University of Edinburgh, UK

Nikolaos Daskalakis
MD, PhD, Associate Professor, Department of Psychiatry, Harvard Medical School, Director, NeuroGenomics & Translational Bioinformatics Laboratory (NG.tbl), McLean Hospital, USA

Costas Demetzos
PhD, Professor, Pharmaceutical Nanotechnology, Director of the Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Athens, Greece

Dennis Douroumis
PhD, Professor, Pharmaceutical Technology and Process Engineering, Director of Centre for Innovation in Process Engineering and Research (CIPER), University of Greenwich, Faculty of Engineering and Science, Medway Campus, Chatham Maritime, UK

Josephine Egan
MD, Chief, Diabetes Section, Laboratory of Clinical Investigation, IRP/NIA/NIH & Clinical Director, IRP/NIA/NIH, USA

Themis Exarchos
PhD, Associate Professor, Department of Informatics, Ionian University, Greece

Panteleimon Giannakopoulos
Medical Direction, University of Geneva Hospitals and Faculty of Medicine, University of Geneva, Switzerland

Michael Hanias
PhD, Associate Professor, Physics Department, Democritus University of Thrace, Greece

Michael Harney
CEO, Terrahertz Ventures, USA

Nikolaos Hatzakis
PhD, Professor, Director of NovoNordisk foundation Center for 4D cellular dynamics, & Director of NovoNordisk Challenge Center for Optimized oligo escape and control of disease, Department of Chemistry & Nano-Science Center, Novo Nordisk Foundation Center for Protein Research, Denmark

Chara Kani
MSc, PhD, Head of the Department of Planning and Monitoring of Drug Administration at the Drug Directorate, General Directorate of Organization and Planning of Health Services, E.O.P.Y.Y., Greece

Dimitrios Kapogiannis
MD, Clinical Investigator, Human Neuroscience Section/Laboratory of Clinical Investigation, NIA/NIH, USA

Thrasyvoulos (Thras) Karydis
Co-Founder & Chief Technical Officer, DeepCure Inc

Clifford Kentros
PhD, Professor, Kavli Institute of Systems Neuroscience, Norwegian University of Science and Technology (NTNU), Norway

Constantine Lyketsos
MD, MHS, Elizabeth Plank Althouse Professor, Johns Hopkins University & Chair, Department of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview, USA

Vasiliki Machairaki
PhD, Assistant Professor, Department of Genetic Medicine, Johns Hopkins, USA

Muniz-Terrera Graciela
PhD, Professor, Social Medicine, Ohio University, USA & Chair of Ageing, Health and Methods, Edinburgh Dementia Prevention, University of Edinburgh, UK

Nikolaos Naziris
MSc, PhD, Pharmacist, Department of Pharmacy, University of Athens, Greece

Kyung-Min-Noh
PhD, Group Leader, Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

Vasilis Ntziachristos
PhD, Professor, Chair of Biological Imaging (CBI) – Technical University Munich, Germany & Director, Institute of Biological and Medical Imaging (IBMI) – Helmholtz Munich, Germany

Javier Ortiz
PhD, Assistant Professor, University of Texas Health Science Center at Houston (UTHealth), Houston Neurocognitive Disorders Center, Department of Neurology, USA

Gerorge Paxinos
PhD, HMRC Senior Principal Research Fellow, Neuroscience Research Australia and Scientia Professor, The University of New South Wales, Australia

Christos Plakiotis
MD, Unit Head, Aged Persons Mental Health Service, Monash Health Adjunct Senior Lecturer, Department of Psychiatry, Monash University, Australia

Paul Rosenberg
MD, Professor, Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, USA

Nikolaos Scarmeas
MD, MS, Associate Professor, Neurology, Columbia University, USA & Professor, Neurology, University of Athens, Greece

Paul Schulz
MD, Professor, Director, Neurocognitive Disorders Center, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), USA

Paige Seegan
PhD, Assistant Professor, Psychiatry and Behavioral Sciences & Director of Behavior Medicine Services for the Division of Pediatric Nephrology and Pediatric Dialysis Program, Johns Hopkins University, USA

Georgios Skretas
PhD, Director, Institute for Bio-innovation, Biomedical Sciences Research Center “Alexander Fleming”, Greece & Associated Researcher, Institute of Chemical Biology, National Hellenic Research Foundation, Greece

Ioannis Sotiropoulos
PhD, Researcher C, Group leader, Institute of Biosciences & Applications, NCSR Dimokritos, Greece

Nuno Sousa
MD, PhD, Professor & President of the School of Medicine, University of Minho, Portugal

Stavros Stavrinides
PhD, Professor, Physics Department, Democritus University of Thrace, Greece

Stavros Taraviras
PhD, Professor, Director Stem Cell Laboratory, Department of Physiology at the Medical School, University of Patras, Greece

Nektarios Tavernarakis
PhD, Chairman, Foundation for Research and Technology-Hellas (FORTH) & Research Director, Institute of Molecular Biology and Biotechnology, FORTH & Professor, Medical School, University of Crete, Greece

Taisuke Tomita
PhD, Professor, Laboratory of Neuropathology and Neuroscience, The University of Tokyo, Japan

Arno Villringer
MD, Professor, Director, Department of Neurology, Max-Planck-Institute for Human Cognitive and Brain Science (MPI CBS), Leipzig, Germany

Dimitrios Vlachakis
PhD, Associate Professor, Genetics, darkDNA (c), Genetics Lab, Biotechnology Dept, School of Applied Biology and Biotechnology, Agr. University of Athens, Greece & Associate Professor / VSL, Algorithm Design & Bioinformatics, Computer Science, Natural and Mathematical Sciences, King’s College London, UK & Vice President of Health Technology Assessment (HTA), National Organization for Medicines (EOF), Ministry of Health, Greece

Ben Wolozin
MD, PhD, Professor, Dept. Of Anatomy & Neurobiology, Dept. of Neurology, Center for Systems Neuroscience and Center for Neurophotonics, Boston University Chobanian & Avedisian School of Medicine, USA

Christos Yapijakis
MS, DMD, PhD, Associate Professor, 1st Department of Pediatrics, School of Medicine, National Kapodistrian University of Athens,”Aghia Sophia” Children’s Hospital, Greece